Add Company
Join Now

Bryleos Revenue and Competitors

License our Company Data API

Johnson City, TN USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Bryleos's estimated annual revenue is currently $697.5k per year.(i)
  • Bryleos's estimated revenue per employee is $77,500

Employee Data

  • Bryleos has 9 Employees.(i)
  • Bryleos grew their employee count by 50% last year.

Bryleos's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CEO and Co-FounderReveal Email/Phone
3
Co-Founder & Chief Financial OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.9M129%N/AN/A
#2
$6M3915%N/AN/A
#3
$5.1M3343%N/AN/A
#4
$1.4M9-18%N/AN/A
#5
$2M130%N/AN/A
#6
$0.8M50%N/AN/A
#7
$10.2M6669%N/AN/A
#8
$1.1M717%N/AN/A
#9
$5M323%N/AN/A
#10
$1.7M11-8%N/AN/A
Add Company

What Is Bryleos?

Early clinical stage therapeutics company developing BNAD101, a patent-pending oral composition of NAD+ clinically proven to increase intracellular NAD+. BNAD101 is a potential high-value medicine to treat challenging and costly neurological disorders. \n\nIn 2022, the Company completed its double-blind, placebo-controlled proof of concept study at the Institute of Systems Biology. The study of 60 healthy adults demonstrated BNAD101 had a 52% increase in intracellular NAD levels against placebo within just 5 days, effectively validating the potential of BNAD101 in treating not only chronic neurological conditions but conditions were swift response is critical.\n\nBryleos: More Life While Living

keywords:N/A

N/A

Total Funding

9

Number of Employees

$697.5k

Revenue (est)

50%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.7M9-10%N/A
#2
$0.9M1011%N/A
#3
$3.5M10-58%N/A
#4
$1M12N/AN/A
#5
$1.2M1417%N/A